Deutsche Bank Sees Value Across Diabetes Devices and Adjacent Industrials, Backing DexCom and Insulet
Deutsche Bank has begun coverage on a set of stocks it views as attractive across the diabetes care ecosystem and in selected healthcare-adjacent areas. The bank highlights improving fundamentals in continuous glucose monitoring and insulin pump markets, names DexCom and Insulet as top picks with Buy ratings, and points to potential upside in a pac…